BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu X, Zhang Y, Li Q. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development. Rev Med Virol 2019;29:e2054. [PMID: 31197909 DOI: 10.1002/rmv.2054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Abeywickrema M, Kelly D, Kadambari S. Management of neonatal central nervous system viral infections: Knowledge gaps and research priorities. Rev Med Virol 2023;:e2421. [PMID: 36639694 DOI: 10.1002/rmv.2421] [Reference Citation Analysis]
2 Li J, Qian H, Pi F. Effects of torularhodin against acetaminophen induced liver injury base on antioxidation, anti-inflammation and anti-apoptosis. Food Bioscience 2023. [DOI: 10.1016/j.fbio.2023.102388] [Reference Citation Analysis]
3 He Y, Wang C, Liang Q, Guo R, Jiang J, Shen W, Hu K. PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1048978] [Reference Citation Analysis]
4 Ciaston I, Dobosz E, Potempa J, Koziel J. The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases. Mol Aspects Med 2022;88:101143. [PMID: 36152458 DOI: 10.1016/j.mam.2022.101143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Zhong X, Xi Z, Li Y, Xu H. Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.11.003] [Reference Citation Analysis]
6 Santamaria P, Bowyer RC, Nibali L. Associations between host genetic variants and Herpes Simplex Labialis in the TwinsUK cohort. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105587] [Reference Citation Analysis]
7 Schmitz Y, Schwerdtfeger M, Westmeier J, Littwitz-salomon E, Alt M, Brochhagen L, Krawczyk A, Sutter K. Superior antiviral activity of IFNβ in genital HSV-1 infection. Front Cell Infect Microbiol 2022;12:949036. [DOI: 10.3389/fcimb.2022.949036] [Reference Citation Analysis]
8 Ivanovskii VA, Antonova IN, Molokova VA. The role of Herpes Simplex Virus type 1 in oral diseases in children. jour 2022;22:143-151. [DOI: 10.33925/1683-3031-2022-22-2-143-151] [Reference Citation Analysis]
9 Feltrin C, Oliveira Simões CM, Marques Sincero TC. Development of a cell-based reporter assay for detection of Human alphaherpesviruses. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101806] [Reference Citation Analysis]
10 Olaniyan MF, Olaniyan TB. Human immunodeficiency virus p24 antigen and antibody, herpes simplex virus-2 IgM and tumor necrosis factor alpha plasma levels in adult female children living in single-parent households: a case-control observational study. Journal of Bio-X Research 2022;5:42-6. [DOI: 10.1097/jbr.0000000000000118] [Reference Citation Analysis]
11 Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU, Mohamed MA. Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med Chem Res 2022;:1-30. [PMID: 35039740 DOI: 10.1007/s00044-021-02832-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Kolerova A, Deeva N, Gileva M, Karabanov I, Popov V, Tropynina A, Shaidurova M, Sergeeva I. On vaccination against sexually transmitted infections. Klin dermatol venerol 2022;21:424. [DOI: 10.17116/klinderma202221041424] [Reference Citation Analysis]
13 Krishnan R, Stuart PM. Developments in Vaccination for Herpes Simplex Virus. Front Microbiol 2021;12:798927. [PMID: 34950127 DOI: 10.3389/fmicb.2021.798927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
14 Попруженко Т, Терехова Т, Боровая М, Белая Т. Modern Aspects of Herpetic Infection with Manifestations in the Oral Cavity. Стоматология. Эстетика. Инновации 2021. [DOI: 10.34883/pi.2021.5.2.007] [Reference Citation Analysis]
15 Nath P, Kabir MA, Doust SK, Ray A. Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques. Infect Dis Rep 2021;13:518-39. [PMID: 34199547 DOI: 10.3390/idr13020049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
16 Heidbuechel JPW, Engeland CE. Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies. J Hematol Oncol 2021;14:63. [PMID: 33863363 DOI: 10.1186/s13045-021-01075-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
17 Rosca AS, Castro J, Sousa LGV, Cerca N. Gardnerella and vaginal health: the truth is out there. FEMS Microbiol Rev 2020;44:73-105. [PMID: 31697363 DOI: 10.1093/femsre/fuz027] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
18 Yi M, Lin S, Zhang B, Jin H, Ding L. Antiviral potential of natural products from marine microbes. Eur J Med Chem 2020;207:112790. [PMID: 32937282 DOI: 10.1016/j.ejmech.2020.112790] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Silke Heilingloh C, Lull C, Kleiser E, Alt M, Schipper L, Witzke O, Trilling M, Eis-Hübinger AM, Dittmer U, Krawczyk A. Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1. Vaccines (Basel) 2020;8:E478. [PMID: 32867086 DOI: 10.3390/vaccines8030478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Xu X, Feng X, Wang L, Yi T, Zheng L, Jiang G, Fan S, Liao Y, Feng M, Zhang Y, Li D, Li Q. A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect. PLoS Pathog 2020;16:e1008703. [PMID: 32776994 DOI: 10.1371/journal.ppat.1008703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ike AC, Onu CJ, Ononugbo CM, Reward EE, Muo SO. Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines (Basel) 2020;8:E302. [PMID: 32545507 DOI: 10.3390/vaccines8020302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
22 Nicoli F, Gallerani E, Sicurella M, Pacifico S, Cafaro A, Ensoli B, Marconi P, Caputo A, Gavioli R. The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation. Vaccines (Basel) 2020;8:E274. [PMID: 32512757 DOI: 10.3390/vaccines8020274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Voellmy R, Bloom DC, Vilaboa N. Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines. Vaccines (Basel) 2020;8:E230. [PMID: 32443425 DOI: 10.3390/vaccines8020230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Treml J, Gazdová M, Šmejkal K, Šudomová M, Kubatka P, Hassan STS. Natural Products-Derived Chemicals: Breaking Barriers to Novel Anti-HSV Drug Development. Viruses 2020;12:E154. [PMID: 32013134 DOI: 10.3390/v12020154] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
25 Xu X, Zhang Y, Li Q. Characteristics of herpes simplex virus infection and pathogenesis suggest a strategy for vaccine development. Rev Med Virol 2019;29:e2054. [PMID: 31197909 DOI: 10.1002/rmv.2054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]